Tech Company Financing Transactions

AnaptysBio Funding Round

On 11/8/2007, AnaptysBio raised $33.9 million in Series B investment from Novo Ventures, Alloy Ventures and Avalon Ventures.

Transaction Overview

Company Name
AnaptysBio
Announced On
11/8/2007
Transaction Type
Venture Equity
Amount
$33,900,000
Round
Series B
Investors

Novo Ventures (Lead Investor) (Heath Lukatch)

Alloy Ventures (Leighton Reed)

Avalon Ventures (Kevin Kinsella)

Frazier Healthcare Partners (James Topper)

Numenor Ventures (Scott Greer)

WS Investment

Proceeds Purpose
The new investment capital will support continued advancement of the company's novel technology for therapeutic antibody discovery and optimization, and building a pipeline of product candidates.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
10421 Pacific Center Ct. 200
San Diego, CA 92121
USA
Phone
(858) 362-6295
Website
www.anaptysbio.com
Email Address
[email protected]
Overview
AnaptysBio (NASDAQ: ANAB) is a leading biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation and immuno-oncology.
Profile
AnaptysBio LinkedIn Company Profile
Social Media
AnaptysBio Company Twitter Account
Company News
AnaptysBio News
Facebook
AnaptysBio on Facebook
YouTube
AnaptysBio on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Hamza Suria
  Hamza Suria LinkedIn Profile  Hamza Suria Twitter Account  Hamza Suria News  Hamza Suria on Facebook
Chief Financial Officer
Eric Loumeau
  Eric Loumeau LinkedIn Profile  Eric Loumeau Twitter Account  Eric Loumeau News  Eric Loumeau on Facebook
Chief Medical Officer
Marco Londei
  Marco Londei LinkedIn Profile  Marco Londei Twitter Account  Marco Londei News  Marco Londei on Facebook
Vice President
Margaret Marino
  Margaret Marino LinkedIn Profile  Margaret Marino Twitter Account  Margaret Marino News  Margaret Marino on Facebook
Vice President
Jason Pinkstaff
  Jason Pinkstaff LinkedIn Profile  Jason Pinkstaff Twitter Account  Jason Pinkstaff News  Jason Pinkstaff on Facebook
Vice President
Nancy Sacco
  Nancy Sacco LinkedIn Profile  Nancy Sacco Twitter Account  Nancy Sacco News  Nancy Sacco on Facebook
VP - Manufacturing
Hemant Kumar
  Hemant Kumar LinkedIn Profile  Hemant Kumar Twitter Account  Hemant Kumar News  Hemant Kumar on Facebook
VP - Regulatory Affairs
Lewis Gryziewicz
  Lewis Gryziewicz LinkedIn Profile  Lewis Gryziewicz Twitter Account  Lewis Gryziewicz News  Lewis Gryziewicz on Facebook

 

 

Browse more venture capital transactions:

Prev: 11/8/2007: Frame Media venture capital transaction
Next: 11/8/2007: ExaGrid Systems venture capital transaction

 

Share this article

 

About Database of VC Transactions

We report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.